Postpartum lymphocytic thyroiditis. Prevalence, clinical course, and long-term follow-up

Area of Science:

• Endocrinology
• Obstetrics & Gynecology
• Immunology

Background:

• Postpartum thyroid disease (PPTD) is a significant concern affecting women after childbirth.
• Early detection and understanding of PPTD are crucial for maternal health management.

Purpose of the Study:

• To determine the incidence and spectrum of thyroid disease in the postpartum period.
• To assess the role of thyroid antibodies in diagnosing postpartum thyroid dysfunction.
• To evaluate the long-term persistence of postpartum thyroid disease.

Main Methods:

• Survey of 238 women at 6 and 12 weeks postpartum for thyroid disease.
• Measurement of microsomal hemagglutinin antibody titers in affected individuals.
• Biopsy in nine patients to confirm lymphocytic thyroiditis.
• Three-year follow-up for 25 of the 27 affected women.

Main Results:

• A total of 11.3% (27/238) of women exhibited thyroid disease.
• Thyroid antibody titers were positive in 56% (15/27) of those with thyroid disease.
• The spectrum included hypothyroidism, thyrotoxicosis, euthyroid goiter, and abnormal thyroxine levels.
• Biopsies confirmed active lymphocytic thyroiditis in all nine patients.
• After three years, 48% (12/25) of affected women still had thyroid disease.
• Only about 25% of cases were clinically obvious.

Conclusions:

• Postpartum thyroid disease has a high incidence, frequently presenting as transient conditions.
• Thyroid antibody testing is essential for identifying subclinical postpartum thyroid disease.
• A significant proportion of postpartum thyroid disease persists long-term, necessitating ongoing monitoring.